EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma

Wanyue Dan, Cenxi Xiong, Guanzhou Zhou, Junzhe Chen, Fei Pan

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-09 · 1880 (4) · 189381

DOI: 10.1016/j.bbcan.2025.189381 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-09. Verfasst von Wanyue Dan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China; Medical School, Nankai …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Colitis-Associated Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 178 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colitis-associated colorectal cancer (CAC) develops as a result of prolonged colitis in patients with inflammatory bowel disease. In recent years, the role of the gut microbiota in colitis-associated colorectal carcinogenesis has begun to be recognized. Specific microbes, such as enterotoxigenic Bacteroides fragilis, Fusobacterium nucleatum, and pks+Escherichia coli, promote carcinogenesis by regulating oncogenic signaling, epithelial-mesenchymal transition, autophagy induction, and the immune microenvironment. Conversely, commensal fungi and probiotics exert tumor-suppressive effects by inhibiting inflammatory pathways and immune cell recruitment. Emerging microbiota-targeted strategies, including precision probiotics and fecal microbiota transplantation, can restore ecological homeostasis, attenuate inflammation, and enhance the efficacy of conventional therapies. This review summarizes the current understanding of the mechanisms underlying microbiota-driven CAC pathogenesis and assesses the potential applications of gut microbiota in the development of diagnostic tools and therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitisColitis-Associated NeoplasmsColorectal NeoplasmsHumansFecal Microbiota TransplantationAnimalsProbioticsTumor MicroenvironmentCarcinogenesis

Stichwörter der Autor:innen

Colitis-associated colorectal cancerGut microbiotaInflammatory bowel diseaseUlcerative colitis

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China; Medical School, Nankai University, Tianjin 300071, China.
  • Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China; Medical School, Nankai University, Tianjin 300071, China. Electronic address: panfei@plagh.or…

Zitieren

APA

Dan, W., Xiong, C., Zhou, G., Chen, J., & Pan, F. (2025). Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(4), 189381. https://doi.org/10.1016/j.bbcan.2025.189381

Vancouver

Dan W, Xiong C, Zhou G, Chen J, Pan F. Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(4):189381. doi:10.1016/j.bbcan.2025.189381

BibTeX
@article{Dan2025,
  author = {Dan, Wanyue and Xiong, Cenxi and Zhou, Guanzhou and Chen, Junzhe and Pan, Fei},
  title = {Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  volume = {1880},
  number = {4},
  pages = {189381},
  doi = {10.1016/j.bbcan.2025.189381}
}
Kostenlos starten →